This podcast demonstrates how to maximize efficiency by reducing human error and consequently improving reliability. 

Martin Lush, Global Vice President of NSF Health Sciences, gives his insights on how companies can go about changing GMP behaviors and in doing so change quality culture.

This podcast covers how the best companies respond in a crisis, using systematic approaches to make the right judgement. Specifically, we focus on understanding the extent of the quality defect, bringing together a strong cross-functional and acting in a timely manner. We also consider the effectiveness of different types of CAPA – particularly why the obvious trio of “discipline, training and procedures” is not good enough.

So many companies waste money on training that has no impact. The learning stays in the classroom and is forgotten in the workplace, where it really matters. 

Did you know that inadequate investigations are the most often cited issue in FDA warning letters? This podcast from expert Andy Barnett addresses the most frequent investigation gaps cited by the FDA and provides a framework for improving investigation reports.

Learn from the latest research on decision making how to use a simple, structured approach that keeps the emotion, stress and bias under control.

Podcast

Learn how to do more with less. This podcast from John Johnson will help you allocate the resources of your role and your team. It includes links to ICH Q9 Quality Risk Management, effective communication strategies and long-term compliance to cGMP. It also covers how human behaviour drives success.

We asked 100 seasoned pharma professionals to share their tips on how to succeed and stay sane. Listen to this podcast to benefit from 1,000s of years of combined experience.

Podcast